miércoles, 7 de octubre de 2026
BuscarExplore
es.VIA.NEWS
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· November 27, 2025

Datavault AI تبرم صفقة بقيمة 7 ملايين دولار مع شركة MTB Mining Ltd.للاستفادة من الموارد الأرضية الخام وتحويلها إلى قوة رقمية عالية القيمة

View original at globenewswire.com
Datavault AI تبرم صفقة بقيمة 7 ملايين دولار مع شركة MTB Mining Ltd.للاستفادة من الموارد الأرضية الخام وتحويلها إلى قوة رقمية عالية القيمة فيلادلفيا, Nov…
Opening lines of the source · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Digital records pave the way toward strengthening lending operations, asset collateralization procedures, and cross-border trade using documented digital assets

    80% confidence

  • For Tanzania, where digital currency mining forms a significant part of export value, verifiable digital asset records represent more than just a technical achievement; they are an important qualitative step toward economic modernization

    80% confidence

  • This deal represents a breakthrough in technology and transparency. By issuing digital versions of physical global assets, we are creating compliant and transparent pathways for investing natural wealth and converting it to monetary value on a global scale.

    80% confidence

  • The innovative digital infrastructure represents a significant opportunity for similar future deals beyond the $7M licensing fee structure

    80% confidence

Data points we hold from this source

Datavault AI Inc. · royalty rate30 percent
Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Autumn 2026 Biopharma Catalyst Season: Late-Breaking Data, FDA Milestones and the Rise of AI-Designed Drugs
Late-September and early-October 2026 conferences (EASD, EADV, IGCS) brought a cluster of positive late-breaking trial readouts. These covered obesity and metabolic disease (Novo Nordisk's CagriSema), immunology (Lilly's EBGLYSS, tulisokibart) and oncology (Rina-S, Agenus BOT+BAL). Ahead lie hard regulatory catalysts, led by the 14 Nov 2026 FDA PDUFA date for ivonescimab. At the same time, Insilico-style AI-designed drugs such as rentosertib are showing anti-aging signals. That points to AI-driven drug discovery moving from concept toward clinical validation. Unrelated tech and regulatory items (Tesla Cybercab probe, xAI litigation, OpenAI agent incident) and the speculative QAIAx claims are peripheral to this story.
Nuestra lectura de los datos ›
Señales que seguimos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patrones que observamos ›
Donde las fuentes discrepan
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,986
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,986 hechos verificados con la fuente5,362 documentos fuente archivados
Consulta estos datos → isubstrate.com
Datavault AI تبرم صفقة بقيمة 7 ملايين دولار مع شركة MTB Mining Ltd.للاستفادة من الموارد الأرضية الخام وتحويلها إلى قوة رقمية عالية القيمة — Source | Via News | es.VIA.NEWS